Citalopram Treatment of Depression in Parkinson's Disease: The Impact on Anxiety, Disability, and Cognition
The DOI matches its Crossref record.
Abstract
Depression in Parkinson's disease (PD) is associated with faster progression of physical symptoms, greater decline in cognitive skills, and greater decline in the ability to care for oneself. The depression in these patients is also frequently comorbid with anxiety. There are no trials that provide data on the impact of depression treatment on anxiety, disability, and cognition in these patients. In this prospective, 8-week, open label trial, 10 patients with PD and major depression, without dementia, were given flexible doses of citalopram. Depression improved significantly and was associated with significant improvements in anxiety symptoms and functional impairment. The drug was well tolerated. This is the first study that provides data suggesting that treating depression in patients with PD may lead to improvements in anxiety and functional capacity. As with all nonrandomized, open-label trials at tertiary research centers, many nonspecific factors may have influenced the results.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Impulse control disorders in parkinson disease: A multicenter case–control study
Voon, V., Sohr, M., Lang, A. E., Potenza, M. N., Siderowf, A. D., Whetteckey, J., Weintraub, D., Wunderlich, G. R., & Stacy, M. (2011) · Annals of Neurology · doi:10.1002/ana.22356 · Cited by 401
Quality of life and depression in Parkinson's disease
Schrag, A. (2006) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2006.05.030 · Cited by 379
The impact of depressive symptoms in early Parkinson disease
Ravina, B., Camicioli, R., Como, P. G., Marsh, L., Jankovic, J., Weintraub, D., & Elm, J. (2007) · Neurology · doi:10.1212/01.wnl.0000268695.63392.10 · Cited by 301
Depression and anxiety related subtypes in Parkinson's disease
Brown, R. G., Landau, S., Hindle, J. V., Playfer, J., Samuel, M., Wilson, K. C., Hurt, C. S., Anderson, R. J., Carnell, J., Dickinson, L., et al. (2011) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2010.213652 · Cited by 183
Anxiety in Parkinson's disease: identification and management
Chen, J. J., & Marsh, L. (2014) · Therapeutic Advances in Neurological Disorders · doi:10.1177/1756285613495723 · Cited by 161
Metadata
- Authors
- Menza, M.
- Venue
- Journal of Neuropsychiatry
- Published
- 2004-08-01
- Volume
- 16
- Issue
- 3
- Pages
- 315-319
- ISSN
- 0895-0172 (ISSN-L)
- OpenAlex
- W1969162959
- Cited by
- 76
- References
- 0
- FWCI
- 4.01
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Citalopram Treatment of Depression in Parkinson's Disease: The Impact on Anxiety, Disability, and Cognition. https://app.cochat.ai/papers/10.1176/appi.neuropsych.16.3.315
- The paper
- Menza, M. (2004). Citalopram Treatment of Depression in Parkinson's Disease: The Impact on Anxiety, Disability, and Cognition. Journal of Neuropsychiatry. https://doi.org/10.1176/appi.neuropsych.16.3.315
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.